USMLE® Step 1 & 2

Kaplan USMLE Step 1: Which factor is involved in the pathogenesis?

UPDATED . 7 MIN READ

If you're preparing for the United States Medical Licensing Examination® (USMLE®) Step 1 exam, you might want to know which questions are most often missed by test-prep takers. Check out this example from Kaplan Medical, and read an expert explanation of the answer. Also check out all posts in this series.

Free study aid when you join the AMA

Medical students who become AMA members can select a free gift from a variety of powerful study aids for the USMLE and COMLEX-USA tests.

Supporting you today as a medical student. Protecting your future as a physician.

A 48-year-old woman comes to the emergency department because of a 16-hour history of confusion, dizziness, and fatigue. The patient has a history of HIV and is currently on antiretroviral therapy. Her temperature is 38.3°C (101.0°F), pulse is 98 beats per minute, respirations are 20 breaths a minute, and blood pressure is 110/72 mm Hg. Physical examination shows petechiae on her lower extremities. Laboratory studies show:

  • Leukocyte count: 13,000/mm3.
  • Hemoglobin: 8.1 g/dL.
  • Platelet count: 75,000/mm3.
  • Haptoglobin: 38 mg/dL.
  • Lactate dehydrogenase (LDH): 305 U/L.
  • Activated partial thromboplastin time (aPTT): 35 seconds.
  • Prothrombin time (PT): 14 seconds
  • Blood urea nitrogen: 29 mg/dL.

Peripheral blood smear shows multiple schistocytes. Which of the following factors is most likely involved in the pathogenesis of this patient's diagnosis?

A. Factor VIII.

B. Fibrinogen.

C. Glycoprotein Ib.

D. Glycoprotein IIb/IIIa.

E. Von Willebrand factor.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The correct answer is E.

Thrombotic thrombocytopenic purpura (TTP) is a rare idiopathic disorder of platelet consumption. Patients with HIV are at higher risk for developing TTP. TTP is caused by deficiency of von Willebrand factor (vWF) metalloproteinase (ADAMTS-13), leading to accumulation of large vWF multimers that trigger platelet aggregation and thrombosis. TTP is characterized by thrombocytopenia (due to platelet consumption), microangiopathic hemolytic anemia, acute kidney injury, fever, and fluctuating transient neurologic signs (including altered mental status and hemiplegia). TTP is on a disease spectrum with hemolytic uremic syndrome (HUS), but HUS generally occurs in children with recent dysentery due to Escherichia coil O157:H7. HUS is also not associated with neurologic changes.

Petechiae is a hallmark finding of platelet disorders such as TTP. Bleeding time is increased, while coagulation studies (aPTT and PT) are normal, unlike disseminated intravascular coagulation (DIC), which is associated with coagulopathy. Increased serum LDH levels, decreased serum haptoglobin levels, and schistocytes on blood smear are all consistent with microangiopathic hemolytic anemia. Microthrombi of the renal vasculature commonly leads to acute kidney injury in TTP. Accumulation of large vWF multimers in TTP causes thrombosis, as vWF facilitates platelet adhesion and aggregation at sites of endothelial injury. Exposed subendothelial collagen binds vWF, which in turn interacts with glycoprotein Ib on the surface of platelets, anchoring platelets to the site of vessel injury.

Choice A: Factor VIII is a clotting factor that circulates bound to vWF in its inactive form and is released from vWF upon activation by thrombin. Hemophilia A is an inherited factor VIII deficiency characterized by increased aPTT without neurologic symptoms, anemia, thrombocytopenia, or acute kidney injury.

 

Did you answer the question correctly?

Log in to get tips to remember and learn more from Kaplan Medical about why the other answer choices can be eliminated.

AMA membership has its advantages

  • Access education programs and study guides to help you thrive.
  • Distinguish yourself with AMA leadership opportunities.
  • Enjoy exclusive perks and savings.

Not a member? Become a member now.

FEATURED STORIES FOR MEDICAL STUDENTS